β-dystroglycan Antibodies

Santa Cruz Biotechnology delivers a wide array of β-dystroglycan monoclonal antibodies for research in understanding this critical protein's role. β-dystroglycan monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). β-dystroglycan is an essential component of the dystrophin-glycoprotein complex, playing a vital role in linking the cytoskeleton to the extracellular matrix in muscle and other tissues. β-dystroglycan maintains cellular integrity and has been implicated in various muscular dystrophies and other diseases. Research focusing on β-dystroglycan has revealed its significance in cell adhesion and signal transduction pathways. Understanding β-dystroglycan function and regulation is important for advancing therapeutic strategies in muscle-related disorders. Ongoing studies of β-dystroglycan continue to uncover new insights into its molecular mechanisms and physiological roles. β-dystroglycan research has highlighted its importance in development and tissue maintenance. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of β-dystroglycan's role in health and disease.